| __timestamp | Biogen Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8532288000 | 2614539000 |
| Thursday, January 1, 2015 | 9523400000 | 3711019000 |
| Friday, January 1, 2016 | 9970100000 | 4560733000 |
| Sunday, January 1, 2017 | 10643900000 | 5475166000 |
| Monday, January 1, 2018 | 11636600000 | 6276700000 |
| Tuesday, January 1, 2019 | 12422500000 | 7081200000 |
| Wednesday, January 1, 2020 | 11639400000 | 7377200000 |
| Friday, January 1, 2021 | 8872000000 | 13634200000 |
| Saturday, January 1, 2022 | 7895100000 | 10612500000 |
| Sunday, January 1, 2023 | 7302200000 | 11301400000 |
| Monday, January 1, 2024 | 9675900000 | 12231500000 |
Data in motion
In the competitive landscape of biotechnology, Regeneron Pharmaceuticals, Inc. and Biogen Inc. have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Biogen's gross profit peaked in 2019, reaching approximately 12.4 billion, before experiencing a decline to around 7.3 billion by 2023. This represents a significant drop of nearly 41% over four years. In contrast, Regeneron has demonstrated a robust upward trend, with its gross profit surging from 2.6 billion in 2014 to an impressive 11.3 billion in 2023, marking a remarkable increase of over 330%. This divergence highlights Regeneron's strategic growth and Biogen's recent challenges. As the biotech industry continues to evolve, these financial insights provide a window into the strategic maneuvers and market dynamics shaping these two industry giants.
Key Insights on Gross Profit: Novo Nordisk A/S vs Biogen Inc.
Gross Profit Comparison: Amgen Inc. and Biogen Inc. Trends
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Biogen Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Biogen Inc. vs MorphoSys AG
Who Generates Higher Gross Profit? Biogen Inc. or Bausch Health Companies Inc.